Prospective study with HEXA-CAF combination in ovarian carcinoma
- 1 April 1981
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 5 (3) , 157-161
- https://doi.org/10.1007/bf00258473
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hexamethylmelamine: An evaluation of its role in the treatment of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1979
- Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.1979
- HEXA-CAF COMBINATION CHEMOTHERAPY AND OTHER MULTIPLE-DRUG REGIMENS IN ADVANCED OVARIAN-CARCINOMA - PRESENT AND FUTURE1979
- The pathological assessment of ovarian neoplasms. III: The malignant ‘Epithelial’ tumoursPathology, 1979
- The pathological assessment of ovarian neoplasms. i: introduction to the common ‘epithelial’ tumours and analysis of benign ‘epithelial’ tumoursPathology, 1979
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.1975
- Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.1968